Compounds > ciprofloxacin

ciprofloxacin and interleukin-8

ciprofloxacin has been researched along with interleukin-8 in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's3 (33.33)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Dubbels, AM; Galley, HF; Nelson, SJ; Webster, NR1
Dhillon, JK; Galley, HF; Paterson, RL; Webster, NR1
Baggiolini, M; Campieri, M; Gionchetti, P; Helwig, U; Kühbacher, T; Lammers, K; Rizzello, F; Schreiber, S; Uguccioni, M1
Blau, H; Fabian, I; Halperin, D; Klein, K; Shalit, I1
Fabian, I; Halperin, D; Priel, E; Reuveni, D; Shalit, I1
Ellström, P; Feodoroff, B; Hänninen, ML; Rautelin, H1
Callaghan, M; Fernandes, F; Ferreira, AS; McClean, S; Moreira, LM; Pilkington, R; Silva, IN1
Darweesh, RS; Sakagami, M1
Ayinala, S; Cho, DY; Grayson, JW; Lim, DJ; Skinner, D; Thompson, HM; Walz, CR; Woodworth, BA; Zhang, S1

Other Studies

9 other study(ies) available for ciprofloxacin and interleukin-8

ArticleYear
Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis.
    Critical care medicine, 1997, Volume: 25, Issue:8

    Topics: Anti-Infective Agents; Cell Line; Ciprofloxacin; Drug Evaluation, Preclinical; Endothelium, Vascular; Humans; Interleukin-6; Interleukin-8; Lung Neoplasms; Nitrites; Sepsis; Tumor Cells, Cultured

1997
Effect of ciprofloxacin on the activation of the transcription factors nuclear factor kappaB, activator protein-1 and nuclear factor-interleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line.
    Clinical science (London, England : 1979), 2000, Volume: 99, Issue:5

    Topics: Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Electrophoresis; Endothelium; Humans; Interleukin-6; Interleukin-8; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA Stability; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation; Tumor Necrosis Factor-alpha

2000
CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue.
    International journal of colorectal disease, 2004, Volume: 19, Issue:2

    Topics: Adult; Antineoplastic Agents; Chemokine CCL2; Chemokine CXCL10; Chemokines, CC; Chemokines, CXC; Ciprofloxacin; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Immunohistochemistry; Interleukin-8; Male; Pouchitis; Proctocolectomy, Restorative; Rifamycins; Rifaximin

2004
Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line.
    American journal of physiology. Lung cellular and molecular physiology, 2007, Volume: 292, Issue:1

    Topics: Anti-Infective Agents; Aza Compounds; Azithromycin; Bronchi; Cell Line; Ciprofloxacin; Cystic Fibrosis; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Fluoroquinolones; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Moxifloxacin; NF-kappa B; Phosphorylation; Quinolines; Tumor Necrosis Factor-alpha

2007
Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects.
    Biochemical pharmacology, 2008, Mar-15, Volume: 75, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Aza Compounds; Camptothecin; Cell Line, Tumor; Ciprofloxacin; DNA; Fluoroquinolones; Humans; Interleukin-8; Moxifloxacin; Quinolines; Topoisomerase I Inhibitors; Vascular Endothelial Growth Factor A

2008
Characterization of clinical Campylobacter jejuni isolates with special emphasis on lipooligosaccharide locus class, putative virulence factors and host response.
    International journal of medical microbiology : IJMM, 2013, Volume: 303, Issue:3

    Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Cell Line; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Enteritis; Epithelial Cells; Humans; Interleukin-8; Lipopolysaccharides; Virulence Factors

2013
The tyrosine kinase BceF and the phosphotyrosine phosphatase BceD of Burkholderia contaminans are required for efficient invasion and epithelial disruption of a cystic fibrosis lung epithelial cell line.
    Infection and immunity, 2015, Volume: 83, Issue:2

    Topics: Albumins; Anti-Bacterial Agents; Bacterial Adhesion; Burkholderia cepacia complex; Burkholderia Infections; Cell Line; Ciprofloxacin; Claudin-1; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Electric Impedance; Humans; Inflammation; Interleukin-6; Interleukin-8; Lung; Membrane Potentials; Mutation; Occludin; Protein Transport; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Respiratory Mucosa; Tight Junctions; Virulence Factors; Zonula Occludens-1 Protein

2015
In vitro lung epithelial cell transport and anti-interleukin-8 releasing activity of liposomal ciprofloxacin.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, Mar-30, Volume: 115

    Topics: Cell Line; Ciprofloxacin; Epithelial Cells; Humans; Interleukin-8; Lipid Bilayers; Liposomes; Lung

2018
Azithromycin and ciprofloxacin inhibit interleukin-8 secretion without disrupting human sinonasal epithelial integrity in vitro.
    International forum of allergy & rhinology, 2021, Volume: 11, Issue:2

    Topics: Azithromycin; Ciprofloxacin; Epithelial Cells; Humans; Interleukin-8; Paranasal Sinuses; Sinusitis

2021